ロード中...
Using Stepwise Pharmacogenomics and Proteomics to Predict Hepatitis C Treatment Response in Difficult to Treat Patient Populations
PURPOSE: In the interferon era of hepatitis C virus (HCV) therapies, genotype/subtype, cirrhosis, prior treatment failure, sex, and race predicted relapse. Our objective is to validate a targeted proteomics platform of 17 peptides to predict sustained virologic response (SVR). EXPERIMENTAL DESIGN: S...
保存先:
| 出版年: | Proteomics Clin Appl |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6353701/ https://ncbi.nlm.nih.gov/pubmed/30058111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prca.201800006 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|